Searched for
ROCHE HOLDING
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Global supply shock not fully priced in, warns David RocheGeopolitical tensions in the Middle East are creating a deceptive calm in global markets, with oil prices failing to reflect significant su...
- Roche Pharma India to appoint Rajwinder Mehdwan as country general managerRoche Pharma India has announced that Rajwinder Mehdwan will take over as the country general manager from April 1, 2025, replacing V Simps...
- European shares rise as US data soothes economic slowdown fearsInvestors are keenly watching a panel discussion of central bankers in Sintra, including European Central Bank President Christine Lagarde,...
- At last, a drug to slow down Alzheimer'sEisai Co, a Tokyo-based pharmaceutical company with a family bent and market capitalisation of $14 billion, crossed the finish line before ...
- Roche gets US nod for Covid-19 antibody testHospitals and reference laboratories can run the Elecsys Anti-SARS-CoV-2 test on one of Roche’s analysis platforms, the company said. Roche...
- Court defers decision on Roche's plea against Zydus' cancer drugRoche sued Zydus Cadila and the DCGI last week, alleging that the Indian company launched its product, Vivitra, in the country without gene...
- Swiss voters reject strictest executive pay limitsSwiss voters rejected a proposal to limit executives’ pay to 12 times that of junior employees on Sunday.
- IPAB revokes two Allergan patents on Ajanta Pharma challengeDrug firm Ajanta Pharma today said it has been successful in its challenge to revoke patents held by Allergan Inc for two drugs used for ey...
- Roche lost Indian patent as it didn't comply local norms:GovernmentRoche lost an Indian patent for breast cancer drug 'Herceptin' as it did not comply with local norms after facing a post grant challenge, g...
- Cipla wins cancer drug patent caseCipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over its version of a lung-ca...
- Roche Holding AG makes $5.7 bn offer for Illumina IncA takeover of Illumina would be Roche’s largest purchase since the $46.8 billion acquisition of Genentech Inc., completed in March 2009.
- Cipla to partner Chinese co in selling Roche, Amgen drug clonesCipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...
- Roche says half-year profit down 29 per centPharmaceuticals maker Roche Holding AG says net income was down 29 per cent for the first half after the takeover of Genentech.
- Swiss drugmaker Roche completes Genentech takeoverSwiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.
- Roche seals $47-b Genentech dealSwiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44% of biotech pioneer Genentech that it doesn’t already own, endin...
- Roche makes 'cheaper' bid for GenentechRoche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.
- Roche to force through Ventana mergerPharmaceuticals maker Roche Holding AG said on Tuesday it is poised to complete its acquisition of Ventana Medical Systems Inc.
- EU regulator recalls Roche’s anti-HIV drug on contamination fearsEurope’s drug regulating body on Wednesday recalled an HIV treatment made by Roche Holding because of contamination.
Load More
